Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
Hexarelin
EfficacyHigh
Studies3
Participants409
StatusAvailable

Hexarelin

His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

Hexarelin is a synthetic hexapeptide belonging to the growth hormone releasing peptide (GHRP) family and is recognized as one of the most potent growth hormone secretagogues available. It binds to ghrelin receptors (GHS-R) in the hypothalamus and pituitary gland, triggering powerful growth hormone release and providing unique cardiovascular protective benefits beyond other GHRPs.

Complete Dosing Guide

Quick Reference

100-300
Typical Dose
Variable
Frequency
30-45
Half-Life
SubQ
Route

Administration Method

Subcutaneous injection on empty stomach

Step-by-Step Dosing Protocol

Week 1-2
100 mcg daily
Initial tolerance assessment and receptor sensitization
Single morning dose on empty stomach, monitor for side effects and growth hormone response
Week 3-6
200 mcg daily
Therapeutic dose establishment
Split into 100 mcg morning and 100 mcg evening doses, maintain 3-hour gap from meals
Week 7-12
300 mcg daily
Optimal therapeutic response phase
100 mcg three times daily (morning, afternoon, evening) for maximum growth hormone stimulation
Week 13-16
200 mcg daily
Maintenance and receptor preservation
Return to twice daily dosing to prevent receptor desensitization, consider 2-week break after 16 weeks

Dosing Guidelines

Research Protocol

Starting dose: 100 mcg daily for tolerance assessment. Therapeutic range: 200-300 mcg daily divided into 2-3 administrations. Advanced protocols may use up to 300 mcg daily in divided doses. Most effective when administered on empty stomach, 1 hour before meals or 3 hours after eating.

Simple Explanation

Most people start with a small amount (100 mcg) once a day to see how their body responds, then increase to 200-300 mcg split into 2-3 injections throughout the day. Taking it on an empty stomach works best - wait an hour before eating after your injection.

Mixing & Injection

Technical Instructions

Subcutaneous injection is the preferred and most effective route of administration. Common injection sites include abdominal area, deltoid region, and outer thigh. Rotate injection sites to prevent tissue damage. Use 0.5-1.0 mL insulin syringes with 28-30 gauge needles for optimal comfort and accuracy.

Step-by-Step Guide

Subcutaneous injection is the preferred and most effective route of administration. Common injection sites include abdominal area, deltoid region, and outer thigh. Rotate injection sites to prevent tissue damage. Use 0.5-1.0 mL insulin syringes with 28-30 gauge needles for optimal comfort and accuracy.

Clinical Administration Guidelines

Injection Protocol

  • Subcutaneous injection per protocol
  • Rotate injection sites
  • Consistent daily timing
  • Follow protocol guidelines

Monitoring Schedule

  • Regular progress monitoring
  • Health parameter monitoring
  • Laboratory monitoring
  • Safety monitoring

Dosage Calculator

Loading Calculator...

Medical Disclaimer

Hexarelin is a research chemical not approved by the FDA for human use. This information is for educational purposes only and should not replace professional medical advice. Always consult with a qualified healthcare provider before starting any peptide therapy. Individual results may vary. Not suitable for use by minors, pregnant or nursing women, or individuals with certain medical conditions.